PMID- 37746146
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230926
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
IS  - 1662-453X (Linking)
VI  - 17
DP  - 2023
TI  - The durable effect of acupuncture for episodic migraine: a systematic review and 
      meta-analysis.
PG  - 1211438
LID - 10.3389/fnins.2023.1211438 [doi]
LID - 1211438
AB  - BACKGROUND: Migraine is a common and recurrent type of headache. Avoiding trigger 
      factors is not often successful in reducing headache frequency, duration, and 
      severity. Prophylactic medications may be effective but are limited by strict 
      indications and daily medication intake. This review aimed to investigate the 
      durable effect of acupuncture on episodic migraine. METHODS: Seven databases 
      including Medline, Embase, PubMed, etc., were searched for English and Chinese 
      literature from their inception to 23 November 2022. Two independent reviewers 
      screened the retrieved studies and extracted the data. Primary outcomes were 
      monthly migraine days, monthly migraine attacks, and VAS score at 3 months 
      post-treatment. The risk of bias in included studies was assessed using the 
      Cochrane Risk of Bias 2.0 tool. Meta-analysis was conducted where applicable. 
      RESULTS: Fifteen studies were included in this review. Acupuncture reduced the 
      number of migraine attacks (MD -0.68; 95% CI -0.93, -0.43; p < 0.001), the number 
      of days with migraine (MD -0.86; 95% CI -1.18, -0.55; p < 0.001), and VAS score 
      (MD -1.01; 95% CI -1.30, -0.72; p < 0.001) to a greater degree than sham 
      acupuncture at 3 months after treatment. Significant differences in reducing pain 
      intensity of migraine in favor of acupuncture compared with waitlist (MD -1.84; 
      95% CI -2.31, -1.37; p < 0.001) or flunarizine (MD -2.00; 95% CI -2.35, -1.65; p 
      < 0.001) at 3 months after treatment were found, and the differences reached the 
      minimal clinically important difference (MCID). CONCLUSION: This review found 
      that the durable effect of acupuncture for episodic migraine lasted at least 
      3 months after treatment. More high-quality studies with longer follow-up periods 
      in the future are needed to confirm the findings.
CI  - Copyright (c) 2023 Shi, Miao, Gao, Zhu, Fang and Liu.
FAU - Shi, Hangyu
AU  - Shi H
AD  - Department of Acupuncture, Guang'anmen Hospital, China Academy of Chinese Medical 
      Sciences, Beijing, China.
AD  - Graduate College, Beijing University of Chinese Medicine, Beijing, China.
FAU - Miao, Runyu
AU  - Miao R
AD  - Graduate College, Beijing University of Chinese Medicine, Beijing, China.
AD  - Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese 
      Medical Sciences, Beijing, China.
FAU - Gao, Shuai
AU  - Gao S
AD  - Department of Acupuncture, Guang'anmen Hospital, China Academy of Chinese Medical 
      Sciences, Beijing, China.
FAU - Zhu, Lili
AU  - Zhu L
AD  - Department of Acupuncture, Guang'anmen Hospital, China Academy of Chinese Medical 
      Sciences, Beijing, China.
FAU - Fang, Jiufei
AU  - Fang J
AD  - Department of Acupuncture, Guang'anmen Hospital, China Academy of Chinese Medical 
      Sciences, Beijing, China.
FAU - Liu, Zhishun
AU  - Liu Z
AD  - Department of Acupuncture, Guang'anmen Hospital, China Academy of Chinese Medical 
      Sciences, Beijing, China.
LA  - eng
PT  - Systematic Review
DEP - 20230908
PL  - Switzerland
TA  - Front Neurosci
JT  - Frontiers in neuroscience
JID - 101478481
PMC - PMC10514352
OTO - NOTNLM
OT  - RCTs
OT  - acupuncture
OT  - durable effect
OT  - migraine
OT  - systematic review
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/09/25 06:42
MHDA- 2023/09/25 06:43
PMCR- 2023/01/01
CRDT- 2023/09/25 05:12
PHST- 2023/04/24 00:00 [received]
PHST- 2023/08/21 00:00 [accepted]
PHST- 2023/09/25 06:43 [medline]
PHST- 2023/09/25 06:42 [pubmed]
PHST- 2023/09/25 05:12 [entrez]
PHST- 2023/01/01 00:00 [pmc-release]
AID - 10.3389/fnins.2023.1211438 [doi]
PST - epublish
SO  - Front Neurosci. 2023 Sep 8;17:1211438. doi: 10.3389/fnins.2023.1211438. 
      eCollection 2023.